I understand when someone doesn't want to take on a cheerleader role. I respect that. But that doesn't translate to a "con" for these purposes. Thirty six responders, or even fewer, with stat sig and clinical effect, would represent an unprecedentedly successful advanced AD trial. You give it a fifty/fifty prediction, but I still don't see your cons.
Market Data 
Markets 
AI
